FRANKLIN, Tenn.--(BUSINESS WIRE)--May 5, 2015--
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the
pricing of its previously announced underwritten public offering of
4,500,000 shares of common stock at a public offering price of $66.50
per share, for gross proceeds to the Company of approximately $299.3 million,
before the underwriting discount and offering expenses. In addition, the
Company has granted the underwriters a 30-day option to purchase up to
an additional 675,000 shares of common stock at the public offering
price less the underwriting discount. The Company intends to use the
proceeds from the offering to repay outstanding indebtedness on the
revolving line of credit under its existing amended and restated senior
credit agreement, to fund its acquisition activity and for general
corporate purposes.
BofA Merrill Lynch, Jefferies and UBS Investment Bank are acting as
joint book-running managers for the offering, and Citigroup, Raymond
James, RBC Capital Markets, Avondale Partners, Baird and Craig-Hallum
Capital Group are acting as co-managers. The shares of common stock are
being offered pursuant to the Company’s shelf registration statement on
file with the Securities and Exchange Commission. The offering is made
solely by means of a prospectus supplement and accompanying prospectus,
copies of which may be obtained by contacting: (i) BofA Merrill Lynch,
222 Broadway, New York, New York 10038, Attn: Prospectus Department or
by e-mail at dg.prospectus_requests@baml.com;
(ii) Jefferies, Attention: Equity Syndicate Prospectus Department, 520
Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at (877)
547-6340 or by e-mail at prospectus_department@jefferies.com;
or (iii) UBS Securities LLC, Attention: Prospectus Department, 1285
Avenue of the Americas, New York, NY 10019, or by telephone at
(888) 827-7275.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy these securities in any jurisdiction in
which such offer, solicitation or sale is unlawful.
Forward-Looking Statements
This news release contains forward-looking statements. Generally words
such as “may,” “will,” “should,” “could,” “anticipate,” “expect,”
“intend,” “estimate,” “plan,” “continue,” and “believe” or the negative
of or other variation on these and other similar expressions identify
forward-looking statements. These forward-looking statements are made
only as of the date of this news release. The Company does not undertake
to update or revise the forward-looking statements, whether as a result
of new information, future events or otherwise. Forward-looking
statements are based on current expectations and involve risks and
uncertainties.
About Acadia
Acadia is a provider of inpatient behavioral healthcare services. Acadia
operates a network of 208 behavioral healthcare facilities with
approximately 8,600 beds in 37 states, the United Kingdom and Puerto
Rico. Acadia provides psychiatric and chemical dependency services to
its patients in a variety of settings, including inpatient psychiatric
hospitals, residential treatment centers, outpatient clinics and
therapeutic school-based programs.
Source: Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc.
Brent Turner, President,
615-861-6000